Overview

Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)

Status:
Completed

Trial end date:
2001-07-01

Target enrollment:

Participant gender:

Summary

The objective of this clinical trial was to assess the efficacy and safety of cetirizine HCl syrup vs. loratadine syrup vs. placebo syrup in the treatment of SAR in children 6 to 11 years old.

Phase:

Phase 4

Details

Lead Sponsor:

Johnson & Johnson Consumer and Personal Products Worldwide

Collaborator:

Pfizer

Treatments:

Cetirizine
Loratadine